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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYThe differentiated state of somatic cells provides barriers for the derivation of induced pluripotent stem cells (iPSCs). To address why some
cell types reprogrammore readily than others, we studied the effect of combinedmodulation of cellular signaling pathways. Surprisingly,
inhibition of transforming growth factor b (TGF-b) together with activation ofWnt signaling in the presence of ascorbic acid allows >80%
ofmurine fibroblasts to acquire pluripotency after 1 week of reprogramming factor expression. In contrast, hepatic and blood progenitors
predominantly required only TGF-b inhibition or canonicalWnt activation, respectively, to reprogram at efficiencies approaching 100%.
Strikingly, blood progenitors reactivated endogenous pluripotency loci in a highly synchronous manner, and we demonstrate that
expression of specific chromatin-modifying enzymes and reduced TGF-b/mitogen-activated protein (MAP) kinase activity are intrinsic
properties associated with the unique reprogramming response of these cells. Our observations define cell-type-specific requirements
for the rapid and synchronous reprogramming of somatic cells.INTRODUCTION
Somatic cells can be reprogrammed into induced pluripo-
tent stem cells (iPSCs) by the enforced expression of tran-
scription factor combinations such as Oct4, Klf4, Sox2, and
c-Myc (OKSM) (Takahashi and Yamanaka, 2006), generating
a unique platform to study developmental processes and
model disease in cell culture (Cherry and Daley, 2013). An
intriguing hallmark of induced pluripotency is the compar-
atively low efficiency at which stable pluripotent cell lines
are established, which ranges between 0.1% and 10% for
most somatic cell types (Stadtfeld and Hochedlinger,
2010). This is associatedwith theasynchronous reactivation
of endogenous pluripotency loci including Oct4 (also
known as Pou5f1), Nanog, and Utf1 and a lag phase of 2 or
moreweeks before a self-sufficient pluripotent state is estab-
lished, which is only successful in a small subset of cells (Bu-
ganim et al., 2012; Polo et al., 2012). Studies in fibroblasts,
the most commonly used cells for iPSC derivation, suggest
that the gradual establishment of a chromatin environment
permissive for OKSM activity may underlie these slow and
stochastic reprogrammingkinetics (ApostolouandHoched-
linger, 2013; Koche et al., 2011; Soufi et al., 2012). Intrigu-
ingly, some somatic cell types appear more amenable for
the extensive epigenetic remodeling associated with acqui-
sition of pluripotency. For example, within the hematopoi-
etic system, immature progenitors form iPSCs more readily
than differentiated cells (Eminli et al., 2009); however, the
molecular reasons for this observation remain unknown.574 Stem Cell Reports j Vol. 3 j 574–584 j October 14, 2014 j ª2014 The AIn agreement with the importance of chromatin remodel-
ing for iPSC formation, small molecule compounds that
alter the activity of chromatin-modifying enzymes can facil-
itate fibroblast reprogramming (Li et al., 2013). An example
is the antioxidant ascorbic acid (AA), which serves as a
cofactor for a-ketoglutarate-dependent dioxygenases such
as Tet proteins and JmjC domain-containing histone deme-
thylases (Monfort and Wutz, 2013). Enhancement of iPSC
formation has also been reported upon modulation of
cellular signaling pathways. For example, activation of
Wnt signaling by natural ligands (Marson et al., 2008) or
chemical inhibition of glycogen synthase kinase 3 (GSK3)
(Li and Ding, 2010), an antagonist of CTNNB1 (also known
as b-catenin), has been shown to promote iPSC formation.
However, evidence for an inhibitory roleof theWntpathway
early in reprogramming has also been provided by Aulicino
et al. (2014) and Ho et al. (2013). Inhibition of transforming
growth factor b (TGF-b) signaling supports both early (Li
et al., 2010; Samavarchi-Tehrani et al., 2010) and late events
(Ichida et al., 2009; Maherali and Hochedlinger, 2009) dur-
ing the transition of fibroblasts to a pluripotent state.
Here, we have investigated possible synergisms between
compounds that affect chromatin modulators and cellular
signaling pathways during iPSC reprogramming. In addi-
tion to fibroblasts, we focused on somatic progenitor cells
with the goal to identify cell-intrinsic features that facili-
tate iPSC formation. Taking this approach, we describe
cell-type-specific requirements for the rapid and synchro-
nous acquisition of pluripotency and provide molecularuthors
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amenable to reprogramming.RESULTS
Synergism between Small Molecule Compounds
Allows Highly Efficient Reprogramming of Mouse
Fibroblasts
To study synergisms between signaling pathways during
iPSC formation, we focused on TGF-b and Wnt signaling
because a role for these pathways in fibroblast repro-
gramming has been documented, and highly specific
compounds targeting them are available. Specifically,
we employed the TGF-b antagonist ALK5 inhibitor II
(‘‘iAlk5’’) (Maherali and Hochedlinger, 2009) and the
GSK3b antagonist CHIR99021 (‘‘CHIR’’) (Li et al., 2009),
which activates Wnt signaling by stabilizing CTNNB1. In
light of the importance of chromatin remodeling for iPSC
formation, we included AA, an enzymatic cofactor that
facilitates fibroblast reprogramming (Esteban et al., 2010).
We tested the aforementioned compounds using
‘‘reprogrammable MEFs’’ (mouse embryonic fibroblasts)
(Stadtfeld et al., 2010) engineered to express a doxycycline
(Dox)-inducible cassette encoding OKSM (Sommer et al.,
2009) from a single defined genomic position and a GFP
reporter from the endogenous Oct4 locus, whose expres-
sion is a hallmark of the pluripotent state. We initially
administered Dox and different combinations of com-
pounds for 6 days to reprogrammable MEFs seeded in
bulk. This was followed by 3 days of culture in unsupple-
mented mouse embryonic stem cell (ESC) media to select
for fully reprogrammed cells (Figure 1A). In Dox alone,
these conditions were insufficient for Oct4 reactivation or
to generate stable ESC-like colonies (Figures 1B and 1C;
Figure S1A available online), but each of the three com-
pounds individually allowed small numbers of Dox-inde-
pendent colonies to emerge, with efficiencies ranging
from 0.5% (CHIR) to about 2% (AA and iAlk5) of input cells
(Figure 1B). The dual compound combinations of CHIR
plus AA and CHIR plus iAlk5 slightly elevated colony
numbers (5%), whereas the combination of iAlk5 and AA
led to a more dramatic increase (21%) (Figure 1B). This
synergistic effect was most pronounced when using all
three chemicals together, frequently resulting in Oct4 reac-
tivation at day 6 (Figure S1A) and stable Dox-independent
iPSC colonies at an average efficiency of 41% (Figures 1B
and 1C). For simplicity, we will refer to the combination
of AA, iAlk5, and CHIR as ‘‘3c.’’
Timed withdrawal experiments revealed that a mini-
mum of 3 days of OKSM expression was sufficient for a
small subset (2%) of MEFs to enter a self-sustained plurip-
otent state in the presence of 3c. This was followed by aStem Celldramatic (25-fold) increase in colony numbers between
days 3 and 6 (Figure 1D), after which colony numbers
plateaued. These observations indicate exceptionally rapid
and synchronized acquisition of pluripotency, which is in
stark contrast to the slow and sporadic reprogramming
observed in Dox only (Figure 1D). To accurately determine
reprogramming efficiencies, we conducted single-cell seed-
ing experiments with reprogrammable MEFs that harbor a
ubiquitously expressed red fluorescent dsRed transgene
(Vintersten et al., 2004) (Figure S1B), thus excluding cells
that fail to seed and reducing the risk of scoring satellite
colonies (Smith et al., 2010). This stringent assay showed
that 7 days in Dox plus 3c was sufficient for about 80%
of MEFs to give rise to colonies that maintained ESC-like
morphology in the absence of exogenous OKSM expres-
sion (Figure 1E). This correlated with the reactivation of
Oct4 in the comparatively short time window between
day 4 and day 7 inmost colonies in Dox plus 3c (Figure 1F).
In contrast, less than 2% of MEFs acquired Dox indepen-
dence after 12 days of OKSM expression in Dox only
with Oct4 reactivation occurring late and in rare colonies
(Figures 1E and 1F).
At the molecular level, the synergistic effect exerted by
3c on iPSC formation was accompanied by the upregula-
tion of large numbers of genes including ESC-associated
transcripts such as Tet1, Epcam, Eras, and Nanog in day 4
reprogramming intermediates (Brambrink et al., 2008;
Stadtfeld et al., 2008), which was not seen with individual
compounds (Figures 1G and 1H). Gene Ontology (GO)
analysis supported the conclusion thatmany stem cell-spe-
cific loci were only activated in the presence of all three
compounds, whereas individual chemicals facilitated the
silencing of specific aspects of the somatic program, such
as collagen synthesis (by iAlk5) andmesodermal differenti-
ation potential (by AA) (Table S1). Immunofluorescence
confirmed accelerated reactivation of pluripotency loci
such as Nanog, Utf1, Lin28, and Sall4, whose protein prod-
ucts were detectable in the majority of nascent colonies
at day 6 in Dox plus 3c (Figures S1C and S1D). Together,
these observations suggest a strong synergism between 3c
compounds and reprogramming factors that allows re-
activation of pluripotency loci that remain refractory in
Dox-only conditions or in the presence of individual com-
pounds. Colonies that emerged in Dox plus 3c and in Dox
alone contained similar numbers of cells. An accelerated
cell cycle therefore does not seem to be specifically asso-
ciated with the dramatically increased reprogramming
efficiency (Figure S1E).
Clonal iPSC lines derived in the presence of 3c yielded
chimeras with germline transmission (Figure S1F; Table
S2). This shows that the enhanced reprogramming kinetics
does not come at the expense of impaired functional prop-
erties of derivative pluripotent cell lines.Reports j Vol. 3 j 574–584 j October 14, 2014 j ª2014 The Authors 575
Figure 1. Effect of Combined TGF-b Inhibition, Wnt Activation, and AA on Fibroblast Reprogramming
(A) Approach to identify chemicals that allow MEF reprogramming in 6 days or less.
(B) Percentage of Dox-independent colonies that formed in the presence of indicated compounds after 6 days of exogenous OKSM
expression. Shown are the mean and range of two independent experiments.
(C) Representative alkaline phosphatase (AP) staining of Dox-independent colonies that formed after 6 days of OKSM expression from 500
input MEFs.
(D) Percentage of Dox-independent colonies derived after withdrawal of compound on the indicated day (mean and range of two inde-
pendent experiments). ND, not determined.
(E) Percentage of wells (96-well plate format) seeded with individual dsRed+ reprogrammable MEFs that gave rise to Dox-inde-
pendent Oct4-GFP+ colonies after 12 days in Dox (n = 3 experiments) or 7 days in Dox + 3c (n = 5 experiments). Error bars
show SDs.
(F) Percentage of nascent colonies that contained Oct4-GFP+ cells at the indicated day of reprogramming, measured by fluorescence
microscopy. Error bars indicate SDs of 3 independent experiments with at least 20 colonies analyzed.
(G) Venn diagrams of genes at least 1.5-fold up- or downregulated in reprogramming intermediates derived in the presence of indicated
compounds compared to Dox alone.
(H) Quantification of the top ESC-specific and MEF-specific genes that showed significant expression changes in intermediates derived in
the presence of indicated compounds compared to Dox alone. Select ESC-associated genes exclusively upregulated in Dox plus 3c are
indicated.
See also Figure S1.
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Progenitor Cell Populations
So far, our results show that combined Wnt activation and
TGF-b inhibition in the presence of AA greatly facilitates
the induction of pluripotency upon OKSM expression in
MEFs. We next sought to investigate whether 3c com-
pounds can also enhance the reprogramming of somatic
progenitor cells. Upon bulk culture of purified granulo-
cyte-macrophage progenitors (GMPs), an immature blood576 Stem Cell Reports j Vol. 3 j 574–584 j October 14, 2014 j ª2014 The Acell type previously reported to yield iPSCs at efficiencies
up to 30% after 2 weeks of OKSM expression (Eminli
et al., 2009), we obtained Dox-independent colonies at
numbers corresponding to about 50% of input cells after
3 days in Dox plus 3c (Figure S2A). After 6 days—when
we observed factor-independent colonies in Dox-only con-
ditions at about 5% efficiency—colony numbers in the
presence of 3c exceeded the number of input GMPs, sug-
gesting a propensity to generate satellites.uthors
Figure 2. Reprogramming of Blood Progenitors and Hepatoblasts in 3c Conditions
(A) Representative images of Oct4-GFP and dsRed expression in colonies formed from individual GMPs after 6 days of culture. Note that
most dsRed+ cells are Oct4-GFP+ in Dox + 3c, but not in Dox alone.
(B) Percentage of Oct4-GFP+ cells in wells undergoing reprogramming after single-cell seeding of GMPs and culture for 6 days in Dox only
(n = 18 clonal colonies) or Dox + 3c (n = 20 clonal colonies), measured by flow cytometry.
(C) Percentage of clonal GMP-derived iPSC colonies in which at least 90% of cells were Oct4-GFP+ at the indicated time points. Shown are
the mean and range of 2 or 3 independent experiments with at least 30 colonies analyzed.
(D) Representative superimposed images of GMP-derived colonies on day 4 of reprogramming in Dox + 3c after immunostaining against
indicated pluripotency markers and counterstaining with DAPI.
(E) Quantification of GMP-derived colonies that express indicated pluripotency markers on day 4 of reprogramming in a homogeneous
(Homo; >90% of positive cells) or heterogeneous (Het; 1%–90% of positive cells) fashion or are marker negative (Neg; <1% of positive
cells). Shown are the mean and range of 2 independent experiments with 14 or more colonies scored each.
(F) Representative fluorescence microscopy images of hepatoblast-derived colonies after culture for 6 days.
(G) Quantification of Oct4 expression in hepatoblast-derived colonies on days 3 and 6 of reprogramming as defined for (E). Shown are the
mean and range of 2 independent experiments with 15 or more colonies scored each.
(H) Images of chimeric mice obtained after blastocyst injection of hepatoblast (Hep) iPSCs or GMP iPSCs derived in Dox plus 3c.
See also Figure S2.
Stem Cell Reports
Cell-Type-Specific Requirements for ReprogrammingImportantly, single-cell seeding of dsRed transgenic
GMPs confirmed reprogramming efficiency of 95% in
Dox plus 3c. These experiments also revealed that the
overall percentage of colonies containing Oct4-GFP+ cells
was similarly high with GMPs and MEFs in Dox plus 3c
(Figure S2B). However, whereas almost all nascent GMP-
iPSCs in Dox plus 3c expressed endogenous Oct4 in a
homogeneous manner, MEF-derived colonies in Dox plusStem Cell3c (as well as GMPs in Dox-only conditions) represented a
heterogeneous mixture of Oct4-GFP+ and Oct4-GFP cells
(Figures 2A and S2B). Quantification by flow cytometry
confirmed this difference and documented an average
GFP-labeling index of >95% in the presence of but only
about 40% in the absence of 3c (Figures 2B and S2C).
Time course analyses of clonal GMP cultures revealed that
colonies with a GFP-labeling index of greater than 90%Reports j Vol. 3 j 574–584 j October 14, 2014 j ª2014 The Authors 577
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encompassed all nascent colonies by day 6 (Figure 2C). At
this time, successfully reprogramming cultures initiated
with singleGMPs in the presence of compounds on average
contained over 5,000 Oct4-GFP+ cells and only negligible
numbers of GMP-derived Oct4-GFP cells (Figure S2D).
The pluripotency markers NANOG, UTF1, LIN28, and
SALL4 were also expressed homogeneously by themajority
of colonies obtained after 4 days of culture in Dox plus
3c (Figures 2D and 2E). These results demonstrate that 3c
conditions allow the vast majority of GMPs to acquire
pluripotency in a highly synchronous manner upon
OKSM expression. In contrast, the frequency of colonies
with an Oct4-GFP-labeling index greater than 90% in Dox
only remained below 10% (Figure 2C). Indeed, all GMP-
derived iPSC colonies in Dox only contained cells that
failed to reactivateOct4 (Figures 2B and S2D) and expressed
NANOGandUTF1 in aheterogeneousmanner (Figure S2E).
We next conducted timed Dox-withdrawal experiments
with reprogrammable hepatoblasts, an endodermal pro-
genitor cell unrelated to blood progenitors or MEFs that
can be prospectively isolated by flow cytometry (Gail-
houste, 2012). We observed rapid emergence of Dox-inde-
pendent colonies upon culture of hepatoblasts in Dox plus
3c, but not Dox only (Figure S2F). Similar to GMPs, in the
presence of 3c, themajority of cells within nascent hepato-
blast-derived colonies reactivated Oct4 and expressed
LIN28 and NANOG (Figures 2F and S2G). Quantification
after single-cell seeding showed Oct4 expression in 95%
of hepatoblast-derived colonies in Dox plus 3c, with about
80%of them—but only few colonies in the presence of Dox
only—expressing this locus in a homogeneous manner
(Figures 2G and S2H). Stable iPSC lines derived from
GMPs and hepatoblasts yielded postnatal chimeras upon
blastocyst injection (Figure 2H; Table S2). Together, these
observations show that 3c reprogramming in both hepato-
blasts and GMPs results in rapid and homogeneous reacti-
vation of ESC-specific loci, which is strikingly different
from the stochastic reprogramming response normally
associated with iPSC formation.
Specific Requirements of TGF-b and Wnt Signaling
Modulation for Progenitor Cell Reprogramming
Our MEF experiments had shown a strong synergism
between AA and TGF-b inhibition and maximal repro-
gramming efficiencies upon further addition of CHIR
(see Figure 1B). We therefore asked whether GMPs and
hepatoblasts have similar requirements for signaling
pathway modulation and determined the efficiencies of
iPSC formation upon reprogramming in the presence of
only AA, CHIR, or iAlk5 compared to 3c.
Strikingly, for GMPs, supplementation of reprogram-
ming media with CHIR alone allowed the formation578 Stem Cell Reports j Vol. 3 j 574–584 j October 14, 2014 j ª2014 The Aof similar numbers of Dox-independent colonies after
6 days of OKSM expression as with Dox plus 3c (Figures
3A and 3B). In contrast, colony numbers decreased 5- to
10-fold when using only AA or iAlk5 (Figure 3B). By fluores-
cence microscopy, ‘‘CHIR-only’’ colonies derived from
single-seeded GMPs showed homogeneous Oct4 reactiva-
tion (Figure S3A), and quantification by flow cytometry
confirmed a GFP-labeling index of over 90% (Figure S3B).
Of note, other blood progenitor cell populations including
common myeloid progenitors (CMPs), megakaryocyte-
erythrocyte progenitors (MEPs), and multipotent lineage-
negative Sca1+Kit+ (LSK) cells also formed iPSCs with
similar efficiencies in Dox plus CHIR and Dox plus 3c (Fig-
ure S3C), suggesting that a strong requirement for Wnt
signaling activation is a common feature of blood progen-
itor cell reprogramming.
Other than for GMPs, CHIR had little beneficial effect on
the number of iPSC colonies obtained from hepatoblasts
(Figure 3C). In contrast, these cells yielded Dox-indepen-
dent colonies efficiently in the presence of either iAlk5 or
AA alone, reaching 60%–80% of the numbers seen with
3c (Figure 3C). Accordingly, both of these compounds
facilitated synchronous reactivation of the Oct4 locus
with their combination being equally efficient as 3c
(Figure S3D).
To investigate the reasons for these cell-type-specific
differences, we studied the expression of TGF-b and Wnt
signature genes in MEFs, GMPs, and hepatoblasts. This
revealed pronounced differences, with GMPs exhibiting
significantly lower levels of gene products associated
with both signaling pathways than hepatoblasts and
MEFs (Figure 3D). Among the differentially expressed
genes were many core pathway components such as
Tgfbr2 and different ligands (for TGF-b) and Apc, Fzd1,
Fzd2, and Ctnnb1 (for Wnt). Because CTNNB1 is an impor-
tant mediator of canonical Wnt signaling (Nelson and
Nusse, 2004), we further investigated its role. CTNNB1
rapidly accumulated in purified GMPs cultured in CHIR,
but not Dox only (Figure S3E), consistent with a possible
role in the rapid reprogramming response. Indeed, lentivi-
ral introduction of a stabilized variant of CTNNB1 (Rubin-
feld et al., 1997) into blood progenitor cells resulted in
efficient reactivation of Oct4 in the presence of Dox alone,
which was indistinguishable from the degree of Oct4
reactivation seen with empty virus-transduced cells re-
programmed in the presence of Dox plus 3c (Figure 3E).
We also obtained similar numbers of Dox-independent
colonies with CTNNB1-expressing blood progenitors in
Dox alone and control cells in Dox plus 3c, whereas no
such colonies were seen with control cells in Dox only
(Figures 3F and 3G). This demonstrates that ectopic
CTNNB1 accelerates the OKSM-driven acquisition of
pluripotency similarly efficient as 3c. Enforced Ctnnb1uthors
Figure 3. Modulation of Specific Signaling Pathways during Progenitor Cell Reprogramming
(A) AP staining of Dox-independent colonies after 6 days of culture of 100 reprogrammable GMPs in the presence of indicated compounds
and 3 days in basal ESC media.
(B and C) Quantification of Dox-independent colonies derived from (B) GMPs and (C) hepatoblasts after 6 days of reprogramming in the
presence of Dox and indicated compounds. Colony numbers were normalized to values obtained in Dox plus 3c. Error bars represent the
range of 2 independent experiments with at least 50 colonies for GMPs and 14 for hepatoblasts scored in each experiment and condition.
(D) Heatmap showing TGF-b- and Wnt-associated genes differentially expressed (fold change >3; q < 0.05) in GMPs, hepatoblasts, and
MEFs. Select genes are highlighted.
(E) Representative flow cytometry plots showing Oct4-GFP expression after culture of 100 blood progenitor cells transduced with either
empty or CTNNB1 virus.
(F) AP staining of Dox-independent colonies formed after 6 days of OKSM expression (in 3 days in basal ESC media) in blood progenitor cells
transduced with empty or CTNNB1 virus.
(G) Quantification of Oct4-GFP expression and colony formation formed after transducing blood progenitor cells with empty or CTNNB1
virus (n = 3 wells seeded with transduced cells for each condition).
See also Figure S3.
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alone did not result in early activation of Oct4 or increased
colony numbers (Figures S3F and S3G). Together, these
observations show that different cell types require specificStem Cellsignaling pathway modulations for rapid and efficient
reprogramming and suggest that CTNNB1-mediated Wnt
activation is a major facilitator of blood progenitor cell
reprogramming.Reports j Vol. 3 j 574–584 j October 14, 2014 j ª2014 The Authors 579
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Fibroblasts
The results described above provide a rationale for the
specific requirements of MEFs, GMPs, and hepatoblasts
for TGF-b and Wnt modulation during reprogramming.
At the same time, they suggest the existence of additional
molecular differences between GMPs and MEFs that
facilitate rapid and synchronous iPSC formation from the
former. We hypothesized that these differences might
encompass other signaling pathways and/or proteins
involved in the epigenetic remodeling necessary for
reprogramming to pluripotency and subjected the starting
cell populations to additional rounds of bioinformatic
analyses.
As shown in Figure S4A, we identified mitogen-activated
protein (MAP) kinase signaling as significantly more active
in MEFs than in GMPs. We therefore reprogrammed MEFs
in reprogramming media supplemented with 3c and
PD0325901, a specific inhibitor of mitogen-activated ki-
nase kinases 1 and 2 that together with CHIR has been re-
ported to facilitate the conversion of pre-iPSCs into iPSCs
(Silva et al., 2008). Reprogramming in such Dox plus 3cM
(3c plus MAP kinase inhibition) conditions did not affect
the percentage of colonies that contained Oct4-GFP+ cells
compared to 3c, but nascent 3cM colonies exhibited a
more ESC-like morphology and significantly more homo-
geneous reactivation of Oct4 (Figures 4A and S4B). Never-
theless, the majority of colonies in Dox plus 3cM still con-
tained cells that failed to reactivate Oct4, suggesting the
existence of additional reprogramming barriers in MEFs.
Intriguingly, we found that many known epigenetic facili-
tators of iPSC formation (Apostolou and Hochedlinger,
2013; Papp and Plath, 2013) are expressed at higher levels
in GMPs than in MEFs (Figure 4B; Table S3). We therefore
used a gain-of-function approach to assess if any of these
enzymes might elicit a reprogramming response in MEFs
that is similar to GMPs and cloned factors that represent
different chromatin-modifying activities into lentiviral
expression constructs. We chose KDM2B (a H3K36me2 de-
methylase) (Wang et al., 2011), KDM6A (a histone
H3K27me3 demethylase) (Mansour et al., 2012), WDR5
(a histone methyltransferase complex component) (Ang
et al., 2011), EZH2 (a component of polycomb repressive
complex 2) (Onder et al., 2012), SMARCC1 (an ATP-depen-
dent chromatin-remodeling complex component) (Sin-
ghal et al., 2010), and the catalytic domain of the methyl-
cytosine dehydrogenase TET1, which is functionally
equivalent to the catalytic domains of TET2 and TET3
(Hu et al., 2014). When culturing reprogrammable MEFs
transduced with these vectors in Dox plus 3c, we observed
a strong and highly significant increase in the number of
Oct4-GFP+ cells with KDM2B and a more modest response
with SMARCC1 (Figure 4C). We did not observe a positive580 Stem Cell Reports j Vol. 3 j 574–584 j October 14, 2014 j ª2014 The Aeffect onOct4 reactivationwith anyof the other factors (Fig-
ure 4C), suggesting that H3K36me2 demethylation but not
the other tested enzymatic activities are rate limiting during
3c reprogramming of MEFs. Ectopic expression of Kdm2b
also shortened the time of Dox exposure required for MEFs
to enter a self-sustained pluripotent state (Figures 4C and
4D). Introduction of KDM2B into MEFs cultured in reprog-
rammingmedia supplementedwith3cM resulted inOct4 re-
activation in about 80% of day 8 intermediates, suggesting
synergism between this enzyme andMAP kinase inhibition
(Figure 4D).We also observed homogeneous reactivation of
Oct4, Sall4, and Nanog in the majority—about 70%—of
nascent colonies in Kdm2b plus 3cM conditions (Figures
4E and S4E). Together, these results are consistent with the
notion that reduced MAP kinase activity and elevated
expression of specific pluripotency-associated epigenetic
regulators contribute to the unique reprogramming
responseobserved inGMPs,which inpart canbeestablished
in MEFs.DISCUSSION
In this study, we used a controlled genetic system to inves-
tigate to what extent the combinatorial modulation of
TGF-b and Wnt signaling together with the enzymatic
cofactor AA (‘‘3c conditions’’) can facilitate iPSC derivation
from specific somatic cell types. Although these com-
pounds individually have been reported to moderately
facilitate MEF reprogramming, our results demonstrate a
strong synergism between them, which was previously
not appreciated. By extending our studies to hepatoblasts
and blood progenitor cells, we were able to identify
cell-type-specific requirements for highly efficient and syn-
chronized reprogramming to pluripotency. Importantly,
for each of these cell types, we achieved reprogramming
efficiencies of 80% and greater after a week of OKSM
expression, which are among the highest reported to
date. This suggests that a chromatin state allowing OKSM
to engage with appropriate target genes (Soufi et al.,
2012) is quickly established during 3c reprogramming.
The early upregulation of ESC-specific genes, which are
normally subject to silencing mechanisms such as DNA
methylation in somatic cells (Papp and Plath, 2013), sup-
ports this conclusion. Whether 3c compounds modulate
the activity of molecules previously implicated in syn-
chronized iPSC reprogramming responses such as MBD3,
C/EBPA or TET2 (Rais et al., 2013; Di Stefano et al., 2014;
Doege et al., 2012) warrants further investigation.
Of the somatic cells included in our study, MEFs revealed
the most complex requirements for signaling pathway
modulation and allowed highly efficient iPSC formation
only in the presence of all three compounds. In contrast,uthors
Figure 4. Factors Facilitating Synchronous MEF Reprogramming
(A) Quantification of MEF-derived colonies that express Oct4-GFP in a homogeneous or heterogeneous manner or that are negative after
7 days of culture in Dox + 3c or Dox + 3cM. The results are representative of 3 independent experiments with at least 80 colonies scored. p
values for homogeneous colonies were determined with Fisher’s exact test.
(B) Venn diagram showing whether chromatin regulators implicated in enhancing (green) or repressing (red) reprogramming are expressed
at higher levels in GMPs (blue circle) or MEFs (brown circle). Gene names in bold indicate higher expression in pluripotent cells than in
MEFs.
(C) Quantification of Oct4-GFP expression upon ectopic introduction of indicated chromatin regulators in reprogrammable MEFs cultured in
Dox plus 3c for 8 days. p values were calculated with one-way ANOVA (n = 3 or more independent transduction experiments).
(D) Quantification of Oct4-GFP expression in colonies derived upon transduction with empty or KDM2B virus and culture for 8 days in Dox +
3c or + 3cM (n = 3).
(E) Representative phase-contrast and fluorescence images showing Oct4-GFP expression in a colony obtained after Kdm2b expression in
Dox + 3cM.
(F) Model depicting characteristic features of the intrinsic and enhanced reprogramming response of fibroblasts and blood progenitor
cells upon OKSM expression. Cell-type-specific requirements for achieving enhanced reprogramming, such as repression of TGF-b signaling
and increased activity of KDM2B in fibroblasts, are shown. Accumulations of cells represent clonal colonies, with green cells successfully
reprogramming and gray cells failing to reprogram. Thickness of arrows indicates the proportion of particular types of colonies that are
observed under given conditions.
See also Figure S4.
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TGF-b inhibition alone, whereas GMPs required only
Wnt activation—either byGSK3b inhibition or by enforced
expression of Ctnnb1—to rapidly reactivate pluripotency
loci and to enter a pluripotent state. These cell-type-specific
requirements are reflected in the relative strength of
TGF-b and Wnt signaling in the starting cell populations,
suggesting a way to prospectively identify somatic cellStem Celltypes particularly amenable to factor-mediated reprogram-
ming. The observation that AA, a cofactor of chromatin-
modifying enzymes, did not significantly enhance iPSC
formation from blood progenitor cells indicates that
an epigenetic state favorable for reprogramming might
preexist in these cells. However, we cannot rule out that
AAmodulates GMP reprogramming in a way notmeasured
by our assays.Reports j Vol. 3 j 574–584 j October 14, 2014 j ª2014 The Authors 581
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Cell-Type-Specific Requirements for ReprogrammingWe observed marked differences between fibroblasts and
somatic progenitor cells with respect to the synchronicity
of reprogramming, defined as the percentage of cells within
an emerging colony that expresses ESC-specific genes.
Thus, whereas GMPs and hepatoblasts rapidly gave rise
to colonies containing predominantly cells that had
reactivated endogenous pluripotency loci, we only infre-
quently observed nascent MEF-iPSCs with these character-
istics (see the model in Figure 4F). This supports the notion
that specificmolecular features ‘‘prime’’ progenitor cells for
efficient reprogramming. Indeed, reducing MAP kinase
signaling and elevating the levels of the histone demethy-
lase KDM2B—two intrinsic features of GMPs we identi-
fied—facilitated the synchronous reactivation of pluripo-
tency loci in MEFs. This is in agreement with the ability
of KDM2B to activate genes during early phases of iPSC
formation (Liang et al., 2012) and suggests that rapid
removal of epigenetic barriers by this enzyme might be
involved in the remarkable reprogramming response of
GMPs. It will be interesting to study how OKSM factors,
chromatin modulators, and CTNNB1, an interaction part-
ner of pluripotency factors (Kelly et al., 2011), cooperate
to achieve rapid iPSC formation.
Our observation that GMPs can readily acquire pluripo-
tency upon OKSM expression is reminiscent of a recent
report that describes privileged reprogramming properties
of a fast cycling subset within this progenitor cell popula-
tion (Guo et al., 2014). Although our results do not exclude
a role of fast cell-cycle transition in synchronous GMP re-
programming, they imply that the molecular mechanisms
underlying this phenomenon are complex and involve
additional cellular features. The synchronous reactivation
of pluripotency loci in almost all GMP-derived iPSC col-
onies suggests that 3c conditions override any heterogene-
ity that might exist within the GMP pool.
The high colony-formation efficiency of close to 100%
in less than a week, the rapid and homogeneous reactiva-
tion of core pluripotency loci, and the virtual absence of
nonreprogrammed cells upon OKSM expression in blood
progenitors in the presence of 3c resemble reprogramming
kinetics reported after MBD3 ablation in somatic cells (Rais
et al., 2013). This suggests that at least some adult cell types
can achieve so-called nonstochastic or deterministic re-
programming upon more subtle experimental modulation
than the genetic interference with essential endogenous
genes (see model in Figure 4F). Collectively, our results
define cell-type-specific requirements for highly efficient
and synchronous iPSC formation from different somatic
cells by combined modulation of signaling pathways and
chromatin modifiers. This provides a refined framework
for the further exploration of the mechanisms underlying
the erasure of the somatic state and the induction of
pluripotency.582 Stem Cell Reports j Vol. 3 j 574–584 j October 14, 2014 j ª2014 The AEXPERIMENTAL PROCEDURES
Mice
Derivation, handling, and genotyping of reprogrammable mice
(JAX011001) with the Oct4-GFP allele were described previously
(Stadtfeld et al., 2010). dsRed transgenic animals (Vintersten
et al., 2004) were obtained from Jackson Laboratory (JAX006051).
All animal experiments were done in accordance with the guide-
lines of the NYU School of Medicine Institutional Animal Care
and Use Committee.
Cell Culture and Reprogramming
MEFs (Stadtfeld et al., 2008) and hepatoblasts (Gailhouste, 2012)
were isolated from embryonic day 14.5 embryos and GMPs,
CMPs, MEP, and LSK cells from either fetal liver or adult bone
marrow (Akashi et al., 2000). All cell types used for reprogramming
experiments were heterozygous for the inducible OKSM cassette,
Rosa26-rtTA, and Oct4-GFP. Freshly isolated MEFs were expanded
in reduced-oxygen conditions (4%) and used at passages 1 or 2.
For reprogramming, cells were seeded in ESC media (Dulbecco’s
modified Eagle’s medium [DMEM] with 15% fetal bovine serum,
L-glutamine, penicillin-streptomycin, nonessential amino acids,
b-mercaptoethanol, and 1,000 U/ml leukemia inhibitory factor) at
the desired density on a layer of irradiated feeder cells in the pres-
ence of 1 mg/ml Dox. If applicable, L-AA (50 ng/ml), CHIR (3 mM),
TGF-b RI Kinase Inhibitor II (250 nM), and PD0325901 (0.75 mM)
were added. For GMPs and other blood progenitors, cultures were
supplemented with Flt3 ligand (10 ng/ml) and stem cell factor
(20ng/ml) for thefirst 3days of reprogramming.Mediawere replen-
ished every 2-3 days. To facilitate detection of Oct4-GFP expression
in nascent colonies by fluorescent microscopy, reprogramming ex-
periments were conducted in ESCmedia prepared with FluoroBrite
DMEM (Life Technologies) when required. To score factor-indepen-
dent colonies, Dox (and other compounds) was removed by
washing cultures twice with PBS and then maintaining them in
ESCmedia for at least 3 days before colonies were counted by fluo-
rescence microscopy or after alkaline phosphatase staining (Vector
Laboratories). For quantification of Oct4-GFP expression, cultures
were harvested by trypsin digestion, stainedwith DAPI or 7-amino-
actinomycin D to exclude dead cells, acquired on a LSRII cytometer
(BD Biosciences), and analyzed with FlowJo software (TreeStar).
Immunofluorescence
Cells were fixed with paraformaldehyde, permeabilized, and
stained with primary antibodies against OCT4 (Santa Cruz Bio-
technology; sc-8628), NANOG (Abcam; ab808992), UTF1
(Abcam; ab24273), SALL4 (Abcam; ab29112), LIN28 (Abcam;
ab46020), and CTNNB1 (Sigma-Aldrich; C7207) followed by stain-
ing with appropriate secondary antibodies conjugated to either
Alexa Fluor 555 or 647 (Invitrogen). Images were acquired with
a Neo 5.5 cSMOS camera (Andor) and processed and analyzed
using NIS-Elements and Adobe Photoshop.
Lentiviral Vectors
Vesicular stomatitis virus G protein-pseudotyped lentiviral vectors
were produced in 293T cells and concentrated by ultracentrifu-
gation as described in detail before by Sommer et al. (2009).uthors
Stem Cell Reports
Cell-Type-Specific Requirements for ReprogrammingTransduction of MEFs (3 3 104 cells) and blood progenitor cells
(13 105 cells) was carried out in the presence of 5 mg/ml polybrene.Microarray Analysis
For the study of reprogramming intermediates, cultures of reprog-
rammable MEFs at day 4 of OKSM expression were harvested and
stained with biotinylated anti-stage-specific embryonic antigen 1
(SSEA1) antibody (MC-480; eBioscience), followed by allophyco-
cyanin (APC)-conjugated streptavidin and anti-APC microbeads
(Miltenyi Biotec). SSEA1+ cells were enriched to about 90% purity
using magnetic-activated cell sorting columns (Miltenyi Biotec)
according to manufacturer’s instructions. Total RNA extracted
with the miRNeasy Mini Kit (QIAGEN) with an RNA integrity
number value of >8 was subjected to transcriptional analyses
with Affymetrix mouse genome 430 2.0 mRNA expression
microarrays followed by bioinformatic analyses. For the study of
signaling pathways in starting cell populations, expression values
of transcripts characteristic for TGF-b (GO:0007179) and Wnt
signaling (GO:0016055) were extracted from public data sets.ACCESSION NUMBERS
TheNationalCenter for Biotechnology Information’sGeneExpres-
sion Omnibus accession number for the microarray analysis of re-
programming intermediates reported in this paper is GSE59865.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, and three tables and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.
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